AprilBio Co.,Ltd. (KOSDAQ:397030)
South Korea · Delayed Price · Currency is KRW 72,200
+2,700 (3.88%)
At close: Feb 27, 2026
AprilBio Market Cap
AprilBio has a market cap or net worth of 1.69 trillion as of February 27, 2026. Its market cap has increased by 395.83% in one year.
Market Cap
1.69T
Enterprise Value
1.60T
Revenue
8.97B
Ranking
n/a
PE Ratio
n/a
Stock Price
72,200.00
Market Cap Chart
Since July 28, 2022, AprilBio's market cap has increased from 229.75B to 1.69T, an increase of 633.56%. That is a compound annual growth rate of 74.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 1.69T | 32.27% |
| Dec 30, 2025 | 1.27T | 250.56% |
| Dec 30, 2024 | 363.46B | -0.02% |
| Dec 28, 2023 | 363.53B | 96.13% |
| Dec 29, 2022 | 185.35B | -19.33% |
| Jul 28, 2022 | 229.75B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aimed Bio | 3.98T |
| Rznomics | 2.06T |
| JS Link | 1.33T |
| Qurient | 1.30T |
| Inventage Lab | 1.24T |
| ROKIT Healthcare | 1.06T |
| Curocell | 786.56B |
| IntoCell | 762.61B |